Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation

References

• Mossad S B, Longworth D L, Goormastic M, Serkey J M, Keys T F, Bolwell B J. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265–271
   PubMed Web of Science ®Google Scholar
• Kolbe K, Domkin D, Derigs H G, Bhakdi S, Huber C, Aulitzky W E. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143–147
   PubMed Web of Science ®Google Scholar
• Offidani M, Corvatta L, Olivieri A, Rupoli F, Frayfer J, Mele A, et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 1999; 24: 1079–1087
   PubMed Web of Science ®Google Scholar
• Krüger W, Rüssmann B, Kröger N, Salomon C, Ekopf N, Elsner H A, et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation—a 7 year single center investigation of 409 cases. Bone Marrow Transplant 1999; 23: 589–597
   PubMed Web of Science ®Google Scholar
• Ketterer N, Espinouse D, Chomarat M, Dumontet C, Moullet I, Rieux C, et al. Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med 1999; 106: 191–197
   PubMed Web of Science ®Google Scholar
• Chen-Sing C, Boechk M, Seidel K, Clark J G, Kansu E, Madtes D K, et al. Incidence, risk factors, and mortality from pneumonia developing later after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 515–522
   PubMed Web of Science ®Google Scholar
• Becklake M, Crapo R, Buts A, Burrows B, Clausen J, Coates A, et al. Lung function testing: selection of reference values and interpretative strategies. Am Rev Resp Dis 1991; 144: 1202–1218
   PubMed Web of Science ®Google Scholar
• Puig N, de la Rubia J, Remigia M J, Jarque I, Martín G, Cupelli L, et al. Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation. Leuk Lymph 2006; 47: 1488–1494
   PubMed Web of Science ®Google Scholar
• de la Rubia J, Sanz G F, Martín G, Martínez J, Cervera J, Solbes P, et al. Autologous blood stem cell transplantation (ABSCT) for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplant does not prolong disease-free survival. Haematologica 1999; 84: 125–132
   PubMed Web of Science ®Google Scholar
• de la Rubia J, Bladé J, Lahuerta J J, Ribera J M, Martínez R, Alegre A, et al. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study. Haematologica 2006; 91: 621–627
   Google Scholar
• Ascioglu S, Rex J H, de Pauw B, Bennett J E, Bille J, Crokaert F, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14
   PubMed Web of Science ®Google Scholar
• Carlisle P S, Gucalp R, Wiernik P H. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993; 14: 320–324
   PubMed Web of Science ®Google Scholar
• Wong R, Rondon G, Saliba R M, Shannon V R, Giralt S A, Champlin R E, et al. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. Bone Marrow Transplant 2003; 31: 1157–1163
   PubMed Web of Science ®Google Scholar
• Gray R J. A class of K-sample test for comparing the cumulative incidence of competing risk. Ann Statist 1988; 16: 1141–1154
   Web of Science ®Google Scholar
• Pepe M S, Mori M, Kaplan-Meier. Marginal or conditional probability curves in summarizing competing risk failure time data?. Stat Med 1993; 12: 737–751
   PubMed Web of Science ®Google Scholar
• Reich G, Mapara M Y, Reichardt P, Dorken B, Maschmeyer G. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 2001; 27: 525–529
   PubMed Web of Science ®Google Scholar
• Dettenkofer M, Wenzler-Röttele S, Babikir R, Bertz H, Ebrner W, Meyer E, et al. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 2005; 40: 926–931
   PubMed Web of Science ®Google Scholar
• Torrecilla C, Cortes J L, Chamorro C, Rubio J J, Galdós P, Domínguez E. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 1988; 14: 393–398
   PubMed Web of Science ®Google Scholar
• Price K J, Thall P F, Kish S K, Shannon V R, Andersson B S. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876–884
   PubMed Web of Science ®Google Scholar
• Khassawneh B Y, White P, Anaissie E J, Barlogie B, Hiller F C. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002; 121: 185–188
   PubMed Web of Science ®Google Scholar
• Naeem N, Reed M D, Creger R J, Lazarus H M, Hejal R B, Laughlin M J, et al. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?. Bone Marrow Transplant 2006; 37: 119–133
   PubMed Web of Science ®Google Scholar
• Bodey G P, Buckley M, Sathe Y S, Freireich E J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340
   PubMed Web of Science ®Google Scholar
• Reich G, Cornely O A, Sandherr M, Kubin T, Krause S, Einsele H, et al. Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial. Br J Haematol 2005; 130: 265–270
   PubMed Web of Science ®Google Scholar
• Snowdown L, Gibson J, Joshua D E. Frequency of infection in plateau-phase multiple myeloma. Lancet 1994; 344: 262
   Web of Science ®Google Scholar
• Bladé J, Rosiñol L. Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol 2005; 18: 635–652
   PubMed Web of Science ®Google Scholar
• Brockstein B E, Smiley C, Al-Sadir, Williams S F. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885–894
   PubMed Web of Science ®Google Scholar